ViroLogic, Inc. (VLGC) Announces Presentations At The 96th Annual Meeting Of The American Association for Cancer Research
10/19/2005 5:13:14 PM
More...
|
ViroLogic, Inc. (VLGC) To Present At The Lehman Brothers Eighth Annual Global Healthcare Conference On April 1, 2005
10/19/2005 5:13:06 PM
More...
|
ViroLogic, Inc. (VLGC) Phenosense Assay Shown Superior To Virco's Antivirogram
10/19/2005 5:13:05 PM
More...
|
ViroLogic, Inc. (VLGC) And AstraZeneca (AZN) To Conduct Iressa(R) Biomarker Study
10/19/2005 5:12:56 PM
More...
|
ViroLogic, Inc. (VLGC) Announces Presentations On Its eTag Technology At The 2005 American Society of Clinical Oncology
10/19/2005 5:12:54 PM
More...
|
Studies Highlight Utility Of ViroLogic, Inc. (VLGC) Assays In HIV Management At 12th Conference On Retroviruses And Opportunistic Infections
10/19/2005 5:12:52 PM
More...
|
ViroLogic, Inc. (VLGC) Announces Year End 2004 Financial Results
10/19/2005 5:12:49 PM
More...
|
ViroLogic, Inc. (VLGC) Announces Fourth Quarter And Year End 2004 Financial Results Conference Call
10/19/2005 5:12:44 PM
More...
|
ViroLogic, Inc. (VLGC) Assays Used To Characterize And Identify Potential Treatments For Virulent Multi-Drug Resistant Strain Of HIV
10/19/2005 5:12:43 PM
More...
|
Procyon BioPharma Inc. (PBP.TO) Reports Enhanced Cross-Resistance Profile Of Its Lead HIV Protease Inhibitor, PL-100
10/19/2005 5:12:37 PM
More...
|
|